Timing of Initiation of Low Molecular Weight Heparin Administration in Pregnant Women With Antiphospholipid Syndrome

Trial Profile

Timing of Initiation of Low Molecular Weight Heparin Administration in Pregnant Women With Antiphospholipid Syndrome

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Nov 2016

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Antiphospholipid syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Nov 2016 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
    • 18 Nov 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Jan 2017.
    • 28 Jul 2016 Planned End Date changed from 1 Aug 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top